Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Progress of mesenchymal stem cell therapy for neural and retinal diseases.
Promoting physical activity to control multiple sclerosis from childhood.
Role of vitamin D in regulating the neural stem cells of mouse model with multiple sclerosis.
Clostridium perfringens Epsilon Toxin Causes Selective Death of Mature Oligodendrocytes and Central Nervous System Demyelination.
Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.
Event related potential and response time give evidence for a physiological reserve in cognitive functioning in relapsing-remitting multiple sclerosis.
A metabonomics investigation of multiple sclerosis by nuclear magnetic resonance.
Using the random forest method to detect a response shift in the quality of life of multiple sclerosis patients: a cohort study.
Comparison of the 2010 and 2005 versions of the McDonald MRI criteria for dissemination-in-time in Taiwanese patients with classic multiple sclerosis.
[Laquinimod is an oral drug with a marked neuroprotective effect for pathogenetic treatment of multiple sclerosis(review)].
The use of Doppler ultrasound in the diagnosis of chronic cerebrospinal venous insufficiency.
[Neuromyelitis optica in children. Two case reports.]
Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS).
Fluctuations of MS births and UV-light exposure.
Impact of delayed diagnosis and treatment in clinically isolated syndrome and multiple sclerosis.
Antiinflammatory activity of glucomoringin isothiocyanate in a mouse model of experimental autoimmune encephalomyelitis.
Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis.
Immunomodulation by statins: inhibition of cholesterol vs. isoprenoid biosynthesis.
Modulators of Microglia: a Patent Review.
IL-17 induces MIP-1α expression in primary mouse astrocytes via TRPC channel.
The ICF as a framework to collect and interpret data on the extent and variety of disability in neurological conditions.
Dalfampridine in hereditary spastic paraplegia: a prospective, open study.
Diurnal fluctuations in brain volume: Statistical analyses of MRI from large populations.
Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1.
Treatment of Acute Relapses in Multiple Sclerosis.
Pages
« first
‹ previous
…
314
315
316
317
318
319
320
321
322
…
next ›
last »